My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Welcome

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD)

Analysts fell to the sidelines weighing in on and Gilead Sciences (GILDResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Gilead Sciences (GILD)

BMO Capital analyst Matthew Luchini assigned a Hold rating to Gilead Sciences on October 7. The company’s shares closed last Wednesday at $67.63.

According to TipRanks.com, Luchini is a 3-star analyst with an average return of 3.7% and a 40.2% success rate. Luchini covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Madrigal Pharmaceuticals, and Arvinas Holding Company.

Gilead Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $81.29.

See the top stocks recommended by analysts >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on GILD: